The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

Biopharma Cred. Share News (BPCR)

Biopharma Cred. Information

Buy BPCR Shares
Add BPCR to Watchlist
Add BPCR to Alert

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange

Share Price is delayed by 15 minutes

Share Price: 0.84

Bid: 0.838

Ask: 0.842

Change: -0.002 (-0.24%)

Spread: 0.004 (0.477%)

Open: 0.842

High: 0.842

Low: 0.838

Prev. Close: 0.842

BPCR Live Price

Last checked at -

BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

BioPharma Credit To Invest USD191 Million In Pharmaceutical Developer

Mon, 23rd Apr 2018 13:06

LONDON (Alliance News) - Life science-focused debt investor BioPharma Credit PLC said on Monday it has become the lead investor and collateral agent for a USD315.0 million loan to an unnamed pharmaceutical products developer.

BioPharma Credit will provide USD194.0 million with co-investors providing USD121.0 million.

Key terms of the investment includes a five year final maturity and a high single-digit floating coupon. Funding is expected to close in the next 15 days.

Shares in BioPharma Credit were down 0.5% at USD1.03 on Monday.

More News

24 Oct 2018 11:33

BioPharma Credit Increases Placing Size To USD200 Million (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Wednesday it increased the size of its proposed placing to "at least" USD200 million due to strong investor demand.Last Friday,

24 Oct 2018 09:02

BioPharma Credit increases placing following 'strong investor demand'

(Sharecast News) - BioPharma Credit has increased the size of its proposed placing to "at least" $200m on the back of investor demand that exceeded its original target.

19 Oct 2018 11:26

BioPharma Credit To Raise USD150 Million Via Placing (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Friday it intends to raise USD150 million via share placing.The company will issue 146.3 million shares at USD1.025 per share, a 2.9% to a

27 Sep 2018 12:43

BioPharma Credit Interim Net Asset Value Flat, Income Rises Sharply

LONDON (Alliance News) - BioPhamra Credit PLC on Thursday reported a sharp rise in income in the first halfIn the six months ended June, the life sciences debt investment trust increased to

20 Sep 2018 13:31

BioPharma Credit Loans USD150 Million To Amicus Therapeutics

LONDON (Alliance News) - BioPharma Credit PLC said Thursday that it has loaned USD150 million to Amicus Therapeutics Inc, a rare metabolic disease-focused biopharmaceutical company.Under in

2 Jul 2018 12:55

BioPharma Funds USD200 Million TESARO Loan Alongside Other Investors

LONDON (Alliance News) - BioPharma Credit PLC said Monday it has funded, alongside other investors, the USD200 million second tranche of a USD500 million loan to TESARO Inc.The company and

4 May 2018 12:26

Pablo Legorreta Doubles BioPharma Credit Stake To 7.1% (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Friday Pablo Legorreta doubled his stake in the pharmaceutical debt investor in a transaction on Monday.Legorreta - the founder and chief

2 May 2018 16:51

Pharmaceutical Investors Cuts BioPharma Credit Stake Below 3% (ALLISS)

LONDON (Alliance News) - Life-science focused debt investor BioPharma Credit PLC said on Wednesday Pharmaceutical Investors LP sold shares in the company on Tuesday.After the transaction a

1 May 2018 16:26

BioPharma Invests USD194 Million In US Pharma Firm Sebela

LONDON (Alliance News) - BioPharma Credit PLC said Tuesday that it has invested USD194 million in a unit of US-based Sebela Pharmaceuticals Inc.The life science-focused debt investor has a

8 Mar 2018 12:21

BioPharma Credit To Raise USD300 Million As Net Asset Value Rises (ALLISS)

LONDON (Alliance News) - Life sciences debt investor BioPharma Credit PLC said Thursday it has had a "highly successful" 2017 and announced a share issue to raise on